Imagine if your doctor knew exactly how you felt and what you needed every day, not just during a 15-minute appointment. This system lets cancer patients use an app to share their symptoms and preferences in real-time. It acts like a digital bridge, ensuring the medical team adjusts the treatment plan to fit the person, not just the disease.
Cancer care is currently fragmented into silos, lacking technical tools that allow patients to communicate their physical and social needs in real-time to their care teams.
A digital platform for ePROMs and ePREMs integrated with EMRs, and evidence-based patient-centred care pathways.
If you are a platform provider dealing with fragmented patient data — this project developed a digital solution integrated with EMRs that allows real-time tracking of patient-reported outcomes. This improves the value of the software for oncology clinics across 10 different countries.
If you are a clinic manager dealing with inefficient care coordination — this project developed evidence-based care pathways that reduce variations in clinical practice. This optimizes resources in hospital and community care settings.
If you are a software vendor dealing with low user engagement from patients — this project developed a secure interface for ePROMs and ePREMs. This allows for seamless integration of patient voices directly into the clinical workflow.
Based on available project data, specific pricing or licensing costs are not mentioned; the project is funded by a EUR 4,773,470 EU contribution.
Yes, the project is testing the solution across 9 clinical centres in 10 different European countries to ensure it works across various cultures and settings.
Based on available project data, the software is configured on the eHealth platform of SME partner DNV Imatis, but specific licensing terms are not disclosed.
The software is designed to be securely installed and integrated directly into existing Electronic Medical Records (EMRs).
The project runs from 2022-09-01 to 2027-08-31, with the final implementation study and recommendations occurring in years 3 through 5.
The consortium is well-balanced for a translation project, featuring 17 partners across 10 countries. With an 18% industry ratio (3 companies, including 1 SME), the project has the necessary technical infrastructure via DNV Imatis and clinical validation through 5 universities and 3 research institutes, ensuring the tool is both scientifically sound and commercially viable.
Contact OSLO UNIVERSITETSSYKEHUS HF regarding the MyPath implementation guidelines.
Contact us to find out how to integrate these patient-centred care pathways into your health-tech product.
